Since reduced CD4 + T cell counts are associated with decreased levels of pro-inflammatory cytokines such as IL-2 in the circulation [43], we assume that despite an increase in some NK cell subsets, these effector cells are unable to mediate protective anti-tumor immunity in advanced tumors. The gene discussed is CD4; the disease is neoplasm.